Canntab Therapeutics Limited (CTABF)

Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation") announces that the Ontario Securities Commission (the "OSC") has rejected the Corporation's application for a management cease trade order (the "MCTO") dated September 14, 2023, as the Corporation is not viewed as having met all of the criteria for an MCTO.The Corporation filed the MCTO application with the OSC due to an anticipated ...